Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | HTR1B | P28222 | 2/20 | 0.60 |
| ▸ | DRD2 | P14416 | 2/20 | 0.58 |
| ▸ | DRD4 | P21917 | 2/20 | 0.58 |
| ▸ | DRD3 | P35462 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | BCHE | P06276 | 2/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.54 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.54 |
| ▸ | HTR1D | P28221 | 1/20 | 0.53 |
| ▸ | NSD2 | O96028 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19291789 | 0.95 | MEN1 (0.60) | MEN1KMT2AHTR1BDRD2DRD4 | |
| SCHEMBL13862383 | 0.91 | HTR1B (0.62) | MEN1KMT2AHTR1BDRD2DRD4 | |
| SCHEMBL25822239 | 0.89 | HTR1B (0.64) | MEN1KMT2AHTR1BDRD2DRD4 | |
| SCHEMBL12377082 | 0.88 | CHRM2 (0.54) | MEN1KMT2AHTR1BL3MBTL1KDM4E | |
| SCHEMBL11464993 | 0.88 | BCHE (0.68) | MEN1KMT2AL3MBTL1BCHESIGMAR1 | |
| SCHEMBL25819946 | 0.88 | BCHE (0.53) | MEN1KMT2AHTR1BDRD2DRD4 | |
| SCHEMBL13881850 | 0.88 | BCHE (0.53) | MEN1KMT2AHTR1BDRD2DRD4 | |
| SCHEMBL13881613 | 0.87 | CHRM2 (0.56) | MEN1KMT2AHTR1BDRD2DRD4 | |
| SCHEMBL19291581 | 0.87 | CHRM2 (0.56) | MEN1KMT2AHTR1BDRD2DRD4 | |
| SCHEMBL13881688 | 0.87 | CHRM2 (0.53) | MEN1KMT2AHTR1BDRD2DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218549-A1 | ALKOXY COMPOUNDS FOR DISEASE TREATMENT | ACUCELA INC. | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230218549-A1 | ALKOXY COMPOUNDS FOR DISEASE TREATMENT | ALDH1A2, CLN6, AGER | MEN1 4640/4885KMT2A 3008/4885HTR1B 960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.